A synthetic amino acid that inhibits plasmin activity to reduce melanin production. Widely used in Japan for melasma treatment.
by Daiichi Sankyo Healthcare
Japan's first OTC medicine approved for melasma (chloasma) treatment. Contains tranexamic acid 750mg, L-cysteine 240mg, ascorbic acid (vitamin C) 300mg, and pyridoxine hydrochloride (vitamin B6) 6mg per daily dose. Tranexamic acid inhibits plasmin activity to reduce melanin overproduction caused by hormonal factors. Take for 8 weeks maximum per course. Recommended: 2 tablets twice daily. Available in 60 and 240 tablet packages.
by Daiichi Sankyo OTC
Advanced cold remedy targeting throat pain and inflammation with tranexamic acid
This service is for informational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting any supplement regimen.